• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats.

作者信息

Hyde J F, North W G, Ben-Jonathan N

机构信息

Department of Physiology and Biophysics, Indiana University School of Medicine, Indianapolis 46223.

出版信息

Endocrinology. 1989 Jul;125(1):35-40. doi: 10.1210/endo-125-1-35.

DOI:10.1210/endo-125-1-35
PMID:2500328
Abstract

We have recently reported that the posterior pituitary contains PRL-releasing factor (PRF), a small (less than 5000 mol wt) peptide which induces a rapid, hormone-specific, and concentration-dependent stimulation of PRL secretion. Although the identity of posterior pituitary PRF is yet unknown, it is distinct from known PRL secretagogues. Recently, the vasopressin-associated glycopeptide (VAG), which is concentrated in the posterior pituitary, was suggested as a PRF. To investigate whether VAG functions as a PRF, we used Brattleboro rats, which are deficient in arginine vasopressin (AVP), AVP-associated neurophysin, and VAG. Homozygous (DI) and heterozygous (HZ) lactating Brattleboro rats were used. The water consumption of pregnant DI rats (greater than 300 ml/day) was 6-fold higher than that of HZ rats. To correct their water imbalance, DI rats were implanted with osmotic minipumps containing the vasopressin analog 1-desamino-8-D-arginine vasopressin. On days 7-8 of lactation, pups were separated for 6 h, and blood was collected from the dams via a jugular cannula. Upon introduction of the pups, plasma PRL levels increased 100-fold in both DI and HZ rats and remained elevated for the duration of suckling. The suckling-induced rises in plasma oxytocin in DI and HZ rats were also superimposable. The weight gains of the pups of DI and HZ mothers were similar. PRF activity was determined using perifused anterior pituitary cells. Posterior pituitaries from DI and HZ rats contained equivalent amounts of PRF activity. Moreover, purified rat VAG (1.5 and 6.0 micrograms) failed to stimulate PRL release from pituitary cells. The posterior pituitary content of immunoreactive AVP was 2500-fold higher in HZ rats, but the contents of dopamine and oxytocin were similar. It is concluded that VAG neither mediates the suckling-induced rise of plasma PRL, nor stimulates PRL secretion from perifused anterior pituitary cells. Furthermore, posterior pituitaries from DI and HZ rats contain equivalent amounts of PRF activity. Collectively, these data indicate that VAG is not the posterior pituitary PRF.

摘要

相似文献

1
The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats.
Endocrinology. 1989 Jul;125(1):35-40. doi: 10.1210/endo-125-1-35.
2
Posterior pituitary lobectomy abolishes the suckling-induced rise in prolactin (PRL): evidence for a PRL-releasing factor in the posterior pituitary.垂体后叶切除术消除了哺乳引起的催乳素(PRL)升高:垂体后叶中存在催乳素释放因子的证据。
Endocrinology. 1987 Jul;121(1):205-11. doi: 10.1210/endo-121-1-205.
3
The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.大鼠垂体后叶含有一种有效的催乳素释放因子:对灌流的垂体前叶细胞的研究。
Endocrinology. 1987 Oct;121(4):1531-9. doi: 10.1210/endo-121-4-1531.
4
The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
Endocrinology. 1989 Aug;125(2):736-41. doi: 10.1210/endo-125-2-736.
5
Characterization of prolactin-releasing factor in the rat posterior pituitary.
Endocrinology. 1988 Jun;122(6):2533-9. doi: 10.1210/endo-122-6-2533.
6
Lack of the suckling-induced prolactin release in homozygous Brattleboro rats: the vasopressin-neurophysin-glycopeptide precursor may play a role in prolactin release.纯合布拉特洛伯大鼠缺乏吮乳诱导的催乳素释放:血管加压素-神经垂体素-糖肽前体可能在催乳素释放中起作用。
Brain Res. 1989 Dec 11;504(1):165-7. doi: 10.1016/0006-8993(89)91618-1.
7
Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling.促甲状腺激素释放激素对泌乳中期雌性大鼠催产素、血管加压素和催乳素释放的影响:与哺乳的关系。
J Physiol Pharmacol. 1998 Mar;49(1):135-50.
8
Prolactin-releasing factor: cellular origin in the intermediate lobe of the pituitary.催乳素释放因子:垂体中间叶的细胞起源
Endocrinology. 1990 Jun;126(6):3185-92. doi: 10.1210/endo-126-6-3185.
9
Evidence that thyrotropin-releasing hormone and a hypothalamic prolactin-releasing factor may function in the release of prolactin in the lactating rat.
Endocrinology. 1980 Oct;107(4):863-8. doi: 10.1210/endo-107-4-863.
10
Bovine posterior pituitary extract stimulates prolactin release from the anterior pituitary gland in vitro and in vivo in cattle.牛垂体后叶提取物在体外和牛体内均能刺激垂体前叶释放催乳素。
Reprod Domest Anim. 2005 Apr;40(2):184-9. doi: 10.1111/j.1439-0531.2005.00580.x.

引用本文的文献

1
Copeptin in the diagnosis and management of renal tubular disorders.copeptin在肾小管疾病诊断与管理中的应用
Pediatr Nephrol. 2025 Sep 9. doi: 10.1007/s00467-025-06941-9.
2
Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine.精氨酸加压素与 copeptin:兽医学中的比较综述与展望
Front Vet Sci. 2025 Mar 14;12:1528008. doi: 10.3389/fvets.2025.1528008. eCollection 2025.
3
Copeptin: A potential marker for the prediction of poor ovarian reserve in the ınfertile women.copeptin:预测不孕女性卵巢储备功能低下的潜在标志物。
Turk J Obstet Gynecol. 2022 Dec 13;19(4):281-286. doi: 10.4274/tjod.galenos.2022.55856.
4
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.copeptin作为心血管疾病的诊断和预后生物标志物
Front Cardiovasc Med. 2022 Jul 4;9:901990. doi: 10.3389/fcvm.2022.901990. eCollection 2022.
5
Approach to the Patient: "Utility of the Copeptin Assay".患者处理:“ copeptin 检测的效用”。
J Clin Endocrinol Metab. 2022 May 17;107(6):1727-1738. doi: 10.1210/clinem/dgac070.
6
Vasopressin and Copeptin in health and disease.血管加压素和 copeptin 在健康和疾病中的作用。
Rev Endocr Metab Disord. 2019 Sep;20(3):283-294. doi: 10.1007/s11154-019-09509-9.
7
Copeptin in the differential diagnosis of hypotonic polyuria. copeptin 在低张性多尿症的鉴别诊断中的应用。
J Endocrinol Invest. 2020 Jan;43(1):21-30. doi: 10.1007/s40618-019-01087-6. Epub 2019 Jul 31.
8
EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome.EJE 奖 2019:多尿多饮综合征患者的新诊断方法。
Eur J Endocrinol. 2019 Jul;181(1):R11-R21. doi: 10.1530/EJE-19-0163.
9
Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. copeptin 及其在尿崩症和抗利尿激素不适当分泌综合征诊断中的作用。
Clin Endocrinol (Oxf). 2019 Jul;91(1):22-32. doi: 10.1111/cen.13991. Epub 2019 May 8.
10
Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.copeptin 在血管加压素依赖性体液平衡紊乱诊断中的应用。
Nat Rev Endocrinol. 2016 Mar;12(3):168-76. doi: 10.1038/nrendo.2015.224. Epub 2016 Jan 22.